Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L Blum

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Southern Medical Journal|December 1, 1972
Contracture of the vastus intermedius in children: a review of the literature and presentation of two casesJ L Blum
Oncology|August 7, 1999
Xeloda in the treatment of metastatic breast cancerJ L Blum
The Oncologist|February 13, 2001
The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancerJ L Blum
Foot & Ankle International|March 1, 1994
The modified Mitchell osteotomy-bunionectomy: indications and technical considerationsJ L Blum
Journal of Cellular Physiology|April 1, 1988
Role of the cytoskeleton in laminin induced mammary gene expressionJ L Blum, M S Wicha
Experimental Cell Research|December 1, 1987
Regulation of rat mammary gene expression by extracellular matrix componentsJ L Blum, M E Zeigler, M S Wicha
Environmental Health Perspectives|March 1, 1989
Regulation of mammary differentiation by the extracellular matrixJ L Blum, M E Zeigler, M S Wicha
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracilE Van Cutsem, P M Hoff, J L Blum, et al.
Breast Cancer Research and Treatment|May 1, 1997
Guidelines for systemic therapy of early stage breast cancerJ L Blum, S E Jones, J W Fay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trialJ D Hainsworth, S E Jones, R G Mennel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Southern Medical Journal|December 1, 1972
Contracture of the vastus intermedius in children: a review of the literature and presentation of two casesJ L Blum
Oncology|August 7, 1999
Xeloda in the treatment of metastatic breast cancerJ L Blum
The Oncologist|February 13, 2001
The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancerJ L Blum
Foot & Ankle International|March 1, 1994
The modified Mitchell osteotomy-bunionectomy: indications and technical considerationsJ L Blum
Journal of Cellular Physiology|April 1, 1988
Role of the cytoskeleton in laminin induced mammary gene expressionJ L Blum, M S Wicha
Experimental Cell Research|December 1, 1987
Regulation of rat mammary gene expression by extracellular matrix componentsJ L Blum, M E Zeigler, M S Wicha
Environmental Health Perspectives|March 1, 1989
Regulation of mammary differentiation by the extracellular matrixJ L Blum, M E Zeigler, M S Wicha
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2002
Incidence of cardiotoxicity with the oral fluoropyrimidine capecitabine is typical of that reported with 5-fluorouracilE Van Cutsem, P M Hoff, J L Blum, et al.
Breast Cancer Research and Treatment|May 1, 1997
Guidelines for systemic therapy of early stage breast cancerJ L Blum, S E Jones, J W Fay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Paclitaxel with mitoxantrone, fluorouracil, and high-dose leucovorin in the treatment of metastatic breast cancer: a phase II trialJ D Hainsworth, S E Jones, R G Mennel, et al.
Pageof 2